Breaking News Instant updates and real-time market news.

VBLT

VBL Therapeutics

10:34
11/29/16
11/29
10:34
11/29/16
10:34

VBL Therapeutics mentioned positively at Roth Capital

  • 29

    Nov

VBLT VBL Therapeutics

06/06/16
CHDN
06/06/16
NO CHANGE
CHDN
VBL Therapeutics data provides enhanced visibility, says Chardan
Chardan noted that VBL announced that in a Phase II trial involving glioblastoma multiforme patients, VBL's VB-111 drug followed by VB-111 with Avastin led to a statistically significant increase in median overall survival, or OS, of 59 weeks compared to 32 weeks of OS in patients who received VB-111 followed by Avastin only. The firm says that the data reduces the uncertainty of the Phase III trial of VB-111 and "further reinforces the unprecedented nature" of VB-111's Phase II data. The firm keeps a $20 price target and Buy rating on the shares.
06/06/16
ROTH
06/06/16
NO CHANGE
Target $22
ROTH
Buy
VBL Therapeutics' ASCO presentations underscore potential, says Roth Capital
Roth Capital analyst Joseph Pantginis said VBL Therapeutics' two poster presentations on VB-111 at ASCO underscore the platform's potential in various cancers. Most notably, maturing data from an ongoing trial in ovarian cancer showed an "impressive" dose-response relationship, said Pantginis, who keeps a Buy rating and $22 price target on VBL shares.
06/07/16
CHDN
06/07/16
NO CHANGE
Target $20
CHDN
Buy
Chardan continues to see significant upside for VBL Therapeutics
Chardan continues to see significant upside for VBL Therapeutics shares given VB-111 has convincing efficacy signals for rGBM, ovarian, and thyroid cancer types, an immune-therapeutic effect for VB-111 has been supported in the rGBM and ovarian trials, and the product has orphan drug designations in the US and Euripe for rGBM, Fast Track designation by the FDA for rGBM, and a special protocol assessment by the FDA for the Phase III program in rGBM. Chardan rates VBL Therapeutics a Buy with a $20 price target on shares.
06/28/16
HCWC
06/28/16
INITIATION
Target $11
HCWC
Buy
VBL Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started VBL Therapeutics with a Buy rating and $11 price target.

TODAY'S FREE FLY STORIES

IDTI

Integrated Device

$27.00

-0.16 (-0.59%)

09:26
09/22/17
09/22
09:26
09/22/17
09:26
Recommendations
Integrated Device analyst commentary  »

Integrated Device chip…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 05

    Oct

09:25
09/22/17
09/22
09:25
09/22/17
09:25
Conference/Events
DA Davidson engineering analyst holds an analyst/industry conference call »

Engineering &…

RBS

RBS

09:24
09/22/17
09/22
09:24
09/22/17
09:24
Upgrade
RBS rating change  »

RBS upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COR

CoreSite Realty

09:23
09/22/17
09/22
09:23
09/22/17
09:23
Initiation
CoreSite Realty initiated  »

CoreSite Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CONE

CyrusOne

$60.41

-0.35 (-0.58%)

09:22
09/22/17
09/22
09:22
09/22/17
09:22
Initiation
CyrusOne initiated  »

CyrusOne initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

, S

Sprint

09:21
09/22/17
09/22
09:21
09/22/17
09:21
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: T-Mobile US…

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

S

Sprint

EARS

Auris Medical

$0.71

0.0101 (1.44%)

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

FINL

Finish Line

$9.22

-0.21 (-2.23%)

FL

Foot Locker

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 27

    Sep

  • 02

    Oct

  • 16

    May

BWA

BorgWarner

, SEV

Sevcon

$22.00

-0.01 (-0.05%)

09:21
09/22/17
09/22
09:21
09/22/17
09:21
Conference/Events
Sevcon to host special shareholder meeting »

Special Shareholder…

BWA

BorgWarner

SEV

Sevcon

$22.00

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

ICPT

Intercept

$73.70

-24.42 (-24.89%)

09:19
09/22/17
09/22
09:19
09/22/17
09:19
Downgrade
Intercept rating change  »

Intercept downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLR

Digital Realty

09:18
09/22/17
09/22
09:18
09/22/17
09:18
Initiation
Digital Realty initiated  »

Digital Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
09/22/17
09/22
09:18
09/22/17
09:18
Options
Overnight activity included 125 trades in SPX and 21 trades in VIX »

125 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

09:17
09/22/17
09/22
09:17
09/22/17
09:17
Hot Stocks
Conagra Brands to acquire Angie's Artisan Treats, terms not disclosed »

Conagra Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 28

    Sep

09:15
09/22/17
09/22
09:15
09/22/17
09:15
General news
Euro$ interest rate futures have continued to steady »

Euro$ interest rate…

09:15
09/22/17
09/22
09:15
09/22/17
09:15
General news
Breaking General news story  »

Kansas City Federal…

HDSN

Hudson Technologies

$8.47

-0.79 (-8.53%)

09:14
09/22/17
09/22
09:14
09/22/17
09:14
Recommendations
Hudson Technologies analyst commentary  »

Roth says Hudson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

ACN

Accenture

09:11
09/22/17
09/22
09:11
09/22/17
09:11
Recommendations
Accenture analyst commentary  »

Accenture risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 02

    Oct

  • 22

    Oct

FINL

Finish Line

$9.22

-0.21 (-2.23%)

09:10
09/22/17
09/22
09:10
09/22/17
09:10
Hot Stocks
Breaking Hot Stocks news story on Finish Line »

Finish Line still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

DKS

Dick's Sporting

$26.23

-0.31 (-1.17%)

09:05
09/22/17
09/22
09:05
09/22/17
09:05
Hot Stocks
Dick's Sporting to open four new stores in three states in September »

DICK'S Sporting Good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTCC

Key Tronic

$6.84

-0.023 (-0.34%)

, CETX

Cemtrex

$3.21

-0.09 (-2.73%)

09:04
09/22/17
09/22
09:04
09/22/17
09:04
Hot Stocks
Bharat Parikh & Associates responds to Key Tronic's allegations »

Bharat Parikh &…

KTCC

Key Tronic

$6.84

-0.023 (-0.34%)

CETX

Cemtrex

$3.21

-0.09 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:03
09/22/17
09/22
09:03
09/22/17
09:03
General news
Futures point to slightly lower open after new North Korean threats »

Futures are a bit lower…

PGTI

PGT, Inc.

$14.00

0.05 (0.36%)

09:02
09/22/17
09/22
09:02
09/22/17
09:02
Hot Stocks
PGT Innovations sells door glass processing assets for $28M »

PGT Innovations announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

PNM

PNM Resources

09:00
09/22/17
09/22
09:00
09/22/17
09:00
Initiation
PNM Resources initiated  »

PNM Resources initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

FINL

Finish Line

$9.22

-0.21 (-2.23%)

, M

Macy's

$21.16

-0.32 (-1.49%)

08:55
09/22/17
09/22
08:55
09/22/17
08:55
Hot Stocks
Finish Line: Comps down 0.6% in June, down 9% in July, down 4.2% in August »

Finish Line (FINL) says…

FINL

Finish Line

$9.22

-0.21 (-2.23%)

M

Macy's

$21.16

-0.32 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 27

    Sep

WBC

Wabco

$149.19

1.55 (1.05%)

08:55
09/22/17
09/22
08:55
09/22/17
08:55
Conference/Events
Wabco holds a conference call »

Chairman & CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

08:55
09/22/17
09/22
08:55
09/22/17
08:55
Conference/Events
Federal Reserve Bank of Kansas City President to speak at conference »

Kansas City Federal…

08:50
09/22/17
09/22
08:50
09/22/17
08:50
General news
U.S. equities came back under the gun »

U.S. equities came back…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.